Colgate-Palmolive (CL)
Market Price (12/29/2025): $79.74 | Market Cap: $64.6 BilSector: Consumer Staples | Industry: Household Products
Colgate-Palmolive (CL)
Market Price (12/29/2025): $79.74Market Cap: $64.6 BilSector: Consumer StaplesIndustry: Household Products
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.3%, Dividend Yield is 2.8%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.1%, FCF Yield is 5.2% | Weak multi-year price returns2Y Excs Rtn is -39%, 3Y Excs Rtn is -71% | Key risksCL key risks include [1] gross margin pressure from volatile commodity input costs and foreign exchange rates, Show more. |
| Attractive operating marginsOp Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 22% | ||
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 20%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%, CFO LTM is 3.9 Bil, FCF LTM is 3.4 Bil | ||
| Low stock price volatilityVol 12M is 21% | ||
| Megatrend and thematic driversMegatrends include E-commerce & DTC Adoption, Sustainable Consumption, Circular Economy & Recycling, Health & Wellness Trends, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.3%, Dividend Yield is 2.8%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.1%, FCF Yield is 5.2% |
| Attractive operating marginsOp Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 22% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 20%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%, CFO LTM is 3.9 Bil, FCF LTM is 3.4 Bil |
| Low stock price volatilityVol 12M is 21% |
| Megatrend and thematic driversMegatrends include E-commerce & DTC Adoption, Sustainable Consumption, Circular Economy & Recycling, Health & Wellness Trends, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -39%, 3Y Excs Rtn is -71% |
| Key risksCL key risks include [1] gross margin pressure from volatile commodity input costs and foreign exchange rates, Show more. |
Why The Stock Moved
Qualitative Assessment
AI Analysis | Feedback
1. Analyst Downgrades and Trimmed Price Targets
Colgate-Palmolive (CL) experienced downward pressure on its stock in late 2025 due to analyst actions, including Argus downgrading the stock from Buy to Hold in December 2025, citing margin pressures. Additionally, several major banks reportedly trimmed their price targets for the company during this period.
2. Q3 2025 Revenue Slightly Below Expectations
Despite beating earnings per share (EPS) estimates, Colgate-Palmolive's revenue for the third quarter of 2025 was slightly below analysts' expectations. This could have contributed to investor concerns regarding the company's growth trajectory.
Show more
Colgate-Palmolive (CL) experienced downward pressure on its stock in late 2025 due to analyst actions, including Argus downgrading the stock from Buy to Hold in December 2025, citing margin pressures. Additionally, several major banks reportedly trimmed their price targets for the company during this period.
2. Q3 2025 Revenue Slightly Below Expectations
Despite beating earnings per share (EPS) estimates, Colgate-Palmolive's revenue for the third quarter of 2025 was slightly below analysts' expectations. This could have contributed to investor concerns regarding the company's growth trajectory.
Show more
Stock Movement Drivers
Fundamental Drivers
The 0.8% change in CL stock from 9/28/2025 to 12/28/2025 was primarily driven by a 0.8% change in the company's P/E Multiple.| 9282025 | 12282025 | Change | |
|---|---|---|---|
| Stock Price ($) | 79.06 | 79.73 | 0.85% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 19999.00 | 19999.00 | 0.00% |
| Net Income Margin (%) | 14.55% | 14.55% | 0.00% |
| P/E Multiple | 22.02 | 22.21 | 0.85% |
| Shares Outstanding (Mil) | 810.20 | 810.20 | 0.00% |
| Cumulative Contribution | 0.85% |
Market Drivers
9/28/2025 to 12/28/2025| Return | Correlation | |
|---|---|---|
| CL | 0.8% | |
| Market (SPY) | 4.3% | -32.2% |
| Sector (XLP) | 0.3% | 64.4% |
Fundamental Drivers
The -9.0% change in CL stock from 6/29/2025 to 12/28/2025 was primarily driven by a -9.6% change in the company's P/E Multiple.| 6292025 | 12282025 | Change | |
|---|---|---|---|
| Stock Price ($) | 87.59 | 79.73 | -8.98% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 19947.00 | 19999.00 | 0.26% |
| Net Income Margin (%) | 14.52% | 14.55% | 0.15% |
| P/E Multiple | 24.55 | 22.21 | -9.55% |
| Shares Outstanding (Mil) | 812.00 | 810.20 | 0.22% |
| Cumulative Contribution | -8.98% |
Market Drivers
6/29/2025 to 12/28/2025| Return | Correlation | |
|---|---|---|
| CL | -9.0% | |
| Market (SPY) | 12.6% | -20.4% |
| Sector (XLP) | -2.2% | 69.2% |
Fundamental Drivers
The -11.1% change in CL stock from 12/28/2024 to 12/28/2025 was primarily driven by a -13.1% change in the company's P/E Multiple.| 12282024 | 12282025 | Change | |
|---|---|---|---|
| Stock Price ($) | 89.64 | 79.73 | -11.06% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 20106.00 | 19999.00 | -0.53% |
| Net Income Margin (%) | 14.27% | 14.55% | 1.94% |
| P/E Multiple | 25.55 | 22.21 | -13.09% |
| Shares Outstanding (Mil) | 817.70 | 810.20 | 0.92% |
| Cumulative Contribution | -11.07% |
Market Drivers
12/28/2024 to 12/28/2025| Return | Correlation | |
|---|---|---|
| CL | -11.1% | |
| Market (SPY) | 17.0% | 2.5% |
| Sector (XLP) | 0.5% | 74.4% |
Fundamental Drivers
The 7.9% change in CL stock from 12/29/2022 to 12/28/2025 was primarily driven by a 33.8% change in the company's Net Income Margin (%).| 12292022 | 12282025 | Change | |
|---|---|---|---|
| Stock Price ($) | 73.91 | 79.73 | 7.87% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 17741.00 | 19999.00 | 12.73% |
| Net Income Margin (%) | 10.87% | 14.55% | 33.85% |
| P/E Multiple | 32.04 | 22.21 | -30.69% |
| Shares Outstanding (Mil) | 835.70 | 810.20 | 3.05% |
| Cumulative Contribution | 7.77% |
Market Drivers
12/29/2023 to 12/28/2025| Return | Correlation | |
|---|---|---|
| CL | 4.7% | |
| Market (SPY) | 48.4% | 2.8% |
| Sector (XLP) | 13.8% | 71.5% |
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| CL Return | 27% | 2% | -5% | 4% | 17% | -10% | 34% |
| Peers Return | 16% | 38% | -12% | 21% | 26% | 16% | 150% |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 18% | 114% |
Monthly Win Rates [3] | |||||||
| CL Win Rate | 67% | 42% | 50% | 50% | 75% | 42% | |
| Peers Win Rate | 52% | 65% | 42% | 68% | 57% | 52% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 73% | |
Max Drawdowns [4] | |||||||
| CL Max Drawdown | -12% | -12% | -18% | -11% | 0% | -16% | |
| Peers Max Drawdown | -34% | -5% | -26% | -7% | -9% | -23% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: HPQ, HPE, IBM, CSCO, AAPL. See CL Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/26/2025 (YTD)
How Low Can It Go
| Event | CL | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -19.8% | -25.4% |
| % Gain to Breakeven | 24.6% | 34.1% |
| Time to Breakeven | 479 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -22.6% | -33.9% |
| % Gain to Breakeven | 29.2% | 51.3% |
| Time to Breakeven | 146 days | 148 days |
| 2018 Correction | ||
| % Loss | -25.2% | -19.8% |
| % Gain to Breakeven | 33.7% | 24.7% |
| Time to Breakeven | 659 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -31.5% | -56.8% |
| % Gain to Breakeven | 46.0% | 131.3% |
| Time to Breakeven | 378 days | 1,480 days |
Compare to HPQ, HPE, IBM, CSCO, AAPL
In The Past
Colgate-Palmolive's stock fell -19.8% during the 2022 Inflation Shock from a high on 12/31/2021. A -19.8% loss requires a 24.6% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
AI Analysis | Feedback
Think of it as **Procter & Gamble (PG)** for your mouth and pets.
A global consumer goods company much like **Unilever (UL)**, but with a stronger emphasis on dental hygiene and household cleaning products.
AI Analysis | Feedback
```htmlColgate-Palmolive Major Products
- Oral Care Products: A comprehensive range of toothpastes, toothbrushes, and mouthwashes focused on maintaining oral hygiene and health.
- Personal Care Products: Includes soaps, body washes, deodorants, and shampoos designed for daily personal hygiene and grooming.
- Home Care Products: Household cleaning items such as dish soaps, multi-surface cleaners, and fabric softeners for various domestic needs.
- Pet Nutrition Products: Specialized pet foods for dogs and cats, addressing various health needs, life stages, and dietary requirements.
AI Analysis | Feedback
Colgate-Palmolive (CL) primarily sells its products to other companies, which then distribute and sell these products to individual consumers. These direct customers include a wide array of retailers, wholesalers, and distributors across various channels globally.
While Colgate-Palmolive does not typically disclose specific individual customers that account for a material percentage (e.g., 10% or more) of its consolidated net sales in its financial filings, the following are prominent examples of public companies that serve as major customers due to their extensive retail networks and their role as key distributors of consumer packaged goods:
- Walmart Inc. (WMT)
- Amazon.com, Inc. (AMZN)
- The Kroger Co. (KR)
- CVS Health Corporation (CVS)
- Walgreens Boots Alliance, Inc. (WBA)
- Target Corporation (TGT)
- Costco Wholesale Corporation (COST)
AI Analysis | Feedback
null
AI Analysis | Feedback
Noel Wallace, Chairman, President and Chief Executive Officer
Noel Wallace joined Colgate-Palmolive in 1987 and has more than 30 years of experience with the company, progressing through various senior management roles around the world. He served as President, Colgate North America and Global Sustainability from 2010 to 2013, President, Colgate Latin America from 2013 to 2016, and Chief Operating Officer, Global Innovation & Growth and Hill's Pet Nutrition from 2016 to 2018. He became President and Chief Executive Officer in 2019 and was named Chairman in 2020. Mr. Wallace previously served as an Independent Director for Kellanova (formerly Kellogg Company) from 2015 to 2018.
Stanley J. Sutula III, Chief Finance Officer
Stanley J. Sutula III joined Colgate-Palmolive in 2020. He has extensive experience in corporate finance, financial planning and operations, tax, strategic planning, and risk management. Before joining Colgate-Palmolive, Mr. Sutula served as Executive Vice President and Chief Financial Officer at Pitney Bowes Inc. from 2017. He also spent 28 years at IBM Corporation, holding various financial management roles, culminating in his service as IBM's Vice President and Controller. Mr. Sutula has also served on the board of Avaya Holdings Corp.
Shane Grant, Chief Operating Officer, Americas
Shane Grant joined Colgate-Palmolive in 2025. Prior to this, he was Group Deputy CEO, CEO Americas and EVP Dairy, Plant-Based and Global Sales at Danone. He also spent nearly 20 years at The Coca-Cola Company in various leadership roles.
John Hazlin, Chief Growth Officer
John Hazlin is responsible for leading the implementation of Colgate-Palmolive's 2030 Strategic Plan, which includes initiatives focused on enterprise transformation and peer-leading capabilities. He also sets the direction for global categories and global growth functions such as Analytics, Design, Digital, Research & Development, and Supply Chain. Previously, Mr. Hazlin served as President of the Company's Hill's Pet Nutrition business.
Jennifer M. Daniels, Chief Legal Officer and Secretary
Jennifer M. Daniels serves as the Chief Legal Officer and Secretary for Colgate-Palmolive.
AI Analysis | Feedback
Colgate-Palmolive (CL) faces several key business risks, primarily stemming from its global operations and the nature of the consumer goods industry:
- Foreign Exchange Rates and Commodity Price Volatility: As a global company, Colgate-Palmolive is significantly exposed to adverse movements in foreign exchange rates and fluctuations in commodity prices. This can lead to increased input costs for raw materials, such as fats and oils, which directly impact gross profit margins and overall financial performance. Recent reports indicate that input cost inflation has been a major headwind, negatively affecting gross profit margins.
- Global Macroeconomic and Political Instability: Operating in numerous international markets exposes Colgate-Palmolive to risks arising from political uncertainty, macroeconomic instability, and geopolitical events. These include challenges in countries experiencing economic distress, as well as the potential impact of geopolitical conflicts, which can affect the company's ability to sell products competitively and may impact consumer confidence and consumption.
- Cybersecurity Threats: Colgate-Palmolive identifies cybersecurity as a critical risk. The company has a dedicated information security organization and an Enterprise Risk Management Committee that regularly monitors and addresses cybersecurity threats to protect its operations and data.
AI Analysis | Feedback
-
Disruption in the Pet Nutrition segment by direct-to-consumer (DTC) fresh and personalized pet food companies.
Brands like The Farmer's Dog, Ollie, and NomNomNow are rapidly gaining market share in the premium pet food segment. They offer fresh, human-grade, and often personalized meal plans delivered directly to consumers through a subscription model. This directly challenges Hill's Pet Nutrition (a key Colgate-Palmolive brand) which primarily sells traditional kibble and canned food through veterinary clinics and retail stores. This trend taps into the "humanization of pets" and consumers' desire for transparency and high-quality, minimally processed ingredients, posing a significant threat to established dry food market leaders.
-
Emergence of direct-to-consumer (DTC) subscription models for oral care products.
Companies such as Quip are challenging traditional oral care retail by offering aesthetically designed electric toothbrushes bundled with subscription services for brush heads and toothpaste, delivered directly to consumers. This model bypasses conventional retail channels where Colgate-Palmolive has dominant shelf space and strong distribution networks, potentially eroding market share among consumers seeking convenience, design, and a streamlined purchasing experience for everyday essentials.
AI Analysis | Feedback
Colgate-Palmolive is a global consumer products company with main product categories spanning oral care, personal care, home care, and pet nutrition. The addressable markets for these categories are sized as follows:
-
Oral Care:
- Global: The global oral care market was valued at approximately USD 40.56 billion in 2024 and is projected to reach USD 77.87 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.74%.
- U.S.: The U.S. oral care market value reached around USD 11.68 billion in 2024 and is projected to reach almost USD 16.80 billion by 2034, expanding at a CAGR of 3.70%.
-
Personal Care (Beauty and Personal Care Products):
- Global: The global beauty and personal care products market size was valued at USD 557.88 billion in 2024 and is expected to reach USD 818.42 billion by 2033, exhibiting a CAGR of 4.35% during the forecast period (2025-2033).
- U.S.: The U.S. beauty and personal care products market size was estimated at USD 102.73 billion in 2024 and is projected to grow to USD 155.44 billion by 2030, with a CAGR of 7.1% from 2025 to 2030.
-
Home Care (Household Cleaning Products):
- Global: The global home care market attained a value of approximately USD 105.33 billion in 2024 and is further expected to grow at a CAGR of 3.50% during the forecast period of 2025-2034, reaching a value of USD 148.58 billion by 2034.
- U.S.: null
-
Pet Nutrition (Hill's Pet Nutrition):
- Global: The global pet food and treats market was estimated at USD 138.9 billion in 2024 and is estimated to grow at a 6.1% CAGR from 2025 to 2034.
- U.S.: The U.S. pet food market size was calculated at USD 43.48 billion in 2024 with projections indicating a rise from USD 45.39 billion in 2025 to approximately USD 66.88 billion by 2034, expanding at a CAGR of 4.4%.
AI Analysis | Feedback
Colgate-Palmolive (CL) is expected to drive future revenue growth over the next 2-3 years through several key strategies:- Strategic Pricing and Premiumization through Innovation: The company is focused on implementing strategic price increases, especially in regions like Latin America, to offset inflation and contribute to organic sales growth. Alongside this, Colgate-Palmolive is investing in breakthrough and transformational innovation and launching new products, including premium offerings across its oral, personal, home care, and pet nutrition segments, which encourages consumers to "trade up" and drives category growth.
- Expansion and Growth in Emerging Markets: With nearly 50% exposure to faster-growth emerging markets, Colgate-Palmolive aims to leverage its diverse global footprint. Latin America, for example, has shown strong organic growth driven by accepted price increases and innovation. The company is also developing strategies to effectively target urban markets in regions like China and India.
- Continued Strong Performance of Hill's Pet Nutrition: Hill's Pet Nutrition consistently demonstrates strong performance, particularly in the therapeutic segment, and is a significant contributor to the company's overall sales. This segment is expected to continue supporting revenue growth.
- Productivity Initiatives and Cost Management: Colgate-Palmolive is implementing multi-year strategic growth and productivity programs (SGPP). These initiatives are designed to generate cost savings, streamline processes, and improve operational flexibility, thereby funding incremental investments in the business and driving future growth. The company is also investing in digital capabilities and artificial intelligence to enhance efficiency.
AI Analysis | Feedback
Share Repurchases
- In March 2025, Colgate-Palmolive's Board of Directors authorized a new $5 billion share repurchase program, replacing a previous $5 billion program from 2022. Repurchases under this new program began after March 20, 2025.
- The company executed share buybacks of approximately $1.739 billion in 2024, $1.128 billion in 2023, and $1.308 billion in 2022.
- From July 1, 2025, to September 30, 2025, Colgate-Palmolive repurchased 3,052,859 shares for $258.6 million.
Share Issuance
- Information regarding specific dollar amounts of share issuances for capital raising purposes was not readily available in the provided search results.
Outbound Investments
- On April 30, 2025, Colgate-Palmolive completed the acquisition of the Prime100 fresh pet food business, aiming to expand its pet nutrition portfolio.
- In the first nine months of 2025, the company utilized $714 million in investing activities, which included the acquisition of Care TopCo Pty Ltd, the owner of the Prime100 pet food business.
- Total investments in acquisitions and capital expenditures amounted to $0.7 billion in the first nine months of 2025, intended to drive growth and profitability.
Capital Expenditures
- Colgate-Palmolive's capital expenditures were $410 million in 2020, $567 million in 2021, $696 million in 2022, $705 million in 2023, and $561 million in 2024.
- Capital expenditures for 2025 are expected to be approximately 3.0% of Net sales.
- The primary focus of capital spending is on projects designed to yield high after-tax returns, as well as expanding capacity to address long-term growth opportunities and achieve sustainability goals.
Latest Trefis Analyses
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to CL. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11302025 | BF-B | Brown-Forman | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -8.9% | -8.9% | -8.9% |
| 11302025 | CPB | Campbell's | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -7.6% | -7.6% | -9.2% |
| 11212025 | ENR | Energizer | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 13.1% | 13.1% | -5.3% |
| 11212025 | FLO | Flowers Foods | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 5.4% | 5.4% | -1.6% |
| 11142025 | CLX | Clorox | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -5.0% | -5.0% | -6.0% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Colgate-Palmolive
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 78.94 |
| Mkt Cap | 174.8 |
| Rev LTM | 56,496 |
| Op Inc LTM | 7,945 |
| FCF LTM | 7,612 |
| FCF 3Y Avg | 7,390 |
| CFO LTM | 8,702 |
| CFO 3Y Avg | 8,697 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 5.2% |
| Rev Chg 3Y Avg | 3.2% |
| Rev Chg Q | 8.3% |
| QoQ Delta Rev Chg LTM | 2.0% |
| Op Mgn LTM | 19.7% |
| Op Mgn 3Y Avg | 18.8% |
| QoQ Delta Op Mgn LTM | -0.0% |
| CFO/Rev LTM | 20.1% |
| CFO/Rev 3Y Avg | 20.0% |
| FCF/Rev LTM | 17.5% |
| FCF/Rev 3Y Avg | 17.0% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 174.8 |
| P/S | 3.8 |
| P/EBIT | 21.2 |
| P/E | 33.0 |
| P/CFO | 18.8 |
| Total Yield | 5.2% |
| Dividend Yield | 2.1% |
| FCF Yield 3Y Avg | 5.7% |
| D/E | 0.2 |
| Net D/E | 0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -1.0% |
| 3M Rtn | 4.9% |
| 6M Rtn | 10.9% |
| 12M Rtn | 11.8% |
| 3Y Rtn | 73.5% |
| 1M Excs Rtn | -2.4% |
| 3M Excs Rtn | 0.6% |
| 6M Excs Rtn | -1.3% |
| 12M Excs Rtn | -4.6% |
| 3Y Excs Rtn | -6.2% |
Comparison Analyses
FDA Approved Drugs Data
Expand for More| Post-Approval Fwd Returns | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| FDA App # | Brand Name | Generic Name | Dosage Form | FDA Approval | 3M Rtn | 6M Rtn | 1Y Rtn | 2Y Rtn | Total Rtn |
| ANDA203212 | PERIOGARD | chlorhexidine gluconate | solution | 1282016 | 10.0% | 13.9% | 1.7% | 18.2% | 54.1% |
Segment Financials
Revenue by Segment| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Oral, Personal and Home Care | 15,167 | 14,254 | 14,110 | 13,588 | 13,168 |
| Pet Nutrition | 4,290 | 3,713 | 3,311 | 2,883 | 2,525 |
| Total | 19,457 | 17,967 | 17,421 | 16,471 | 15,693 |
| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Oral, Personal and Home Care | 3,882 | 3,348 | 3,495 | 3,594 | 3,505 |
| Pet Nutrition | 806 | 850 | 901 | 793 | 703 |
| Corporate | -704 | -1,305 | -1,064 | -502 | -654 |
| Total | 3,984 | 2,893 | 3,332 | 3,885 | 3,554 |
Price Behavior
Price Behavior
| Market Price | $79.73 | |
| Market Cap ($ Bil) | 64.4 | |
| First Trading Date | 01/03/1977 | |
| Distance from 52W High | -16.7% | |
| 50 Days | 200 Days | |
| DMA Price | $78.42 | $84.69 |
| DMA Trend | down | indeterminate |
| Distance from DMA | 1.7% | -5.9% |
| 3M | 1YR | |
| Volatility | 19.6% | 21.2% |
| Downside Capture | -71.13 | 3.09 |
| Upside Capture | -52.11 | -8.96 |
| Correlation (SPY) | -31.7% | 2.9% |
CL Betas & Captures as of 11/30/2025
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -0.36 | -0.53 | -0.55 | -0.18 | 0.04 | 0.11 |
| Up Beta | -0.23 | 0.02 | 0.12 | 0.10 | 0.17 | 0.17 |
| Down Beta | -0.86 | -0.26 | -0.38 | -0.38 | -0.04 | 0.02 |
| Up Capture | 7% | -60% | -67% | -26% | -7% | 3% |
| Bmk +ve Days | 12 | 25 | 38 | 73 | 141 | 426 |
| Stock +ve Days | 13 | 20 | 28 | 55 | 118 | 386 |
| Down Capture | -58% | -96% | -94% | -1% | 5% | 25% |
| Bmk -ve Days | 7 | 16 | 24 | 52 | 107 | 323 |
| Stock -ve Days | 6 | 21 | 34 | 70 | 130 | 359 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Comparison of CL With Other Asset Classes (Last 1Y) | |||||||
|---|---|---|---|---|---|---|---|
| CL | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | -11.3% | 0.5% | 17.8% | 72.1% | 8.6% | 4.4% | -8.2% |
| Annualized Volatility | 21.1% | 13.9% | 19.4% | 19.3% | 15.2% | 17.0% | 35.0% |
| Sharpe Ratio | -0.66 | -0.20 | 0.72 | 2.70 | 0.34 | 0.09 | -0.08 |
| Correlation With Other Assets | 74.4% | 3.1% | 3.9% | -7.0% | 40.4% | -6.9% | |
ETFs used for asset classes: Sector ETF = XLP, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Comparison of CL With Other Asset Classes (Last 5Y) | |||||||
|---|---|---|---|---|---|---|---|
| CL | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | 0.9% | 5.7% | 14.7% | 18.7% | 11.5% | 4.6% | 30.8% |
| Annualized Volatility | 17.7% | 13.0% | 17.1% | 15.5% | 18.7% | 18.9% | 48.6% |
| Sharpe Ratio | -0.05 | 0.23 | 0.70 | 0.97 | 0.50 | 0.16 | 0.57 |
| Correlation With Other Assets | 72.9% | 22.6% | 8.5% | -2.8% | 37.3% | -0.5% | |
ETFs used for asset classes: Sector ETF = XLP, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Comparison of CL With Other Asset Classes (Last 10Y) | |||||||
|---|---|---|---|---|---|---|---|
| CL | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | 4.1% | 7.3% | 14.8% | 15.3% | 7.0% | 5.3% | 69.2% |
| Annualized Volatility | 19.4% | 14.7% | 18.0% | 14.7% | 17.6% | 20.8% | 55.8% |
| Sharpe Ratio | 0.17 | 0.37 | 0.71 | 0.86 | 0.32 | 0.22 | 0.90 |
| Correlation With Other Assets | 76.2% | 42.2% | 7.2% | 8.5% | 48.9% | 2.6% | |
ETFs used for asset classes: Sector ETF = XLP, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 10/31/2025 | 0.7% | 1.0% | 3.0% |
| 8/1/2025 | -0.4% | 1.0% | 0.3% |
| 4/25/2025 | 1.3% | -2.2% | -0.1% |
| 1/31/2025 | -4.6% | -5.7% | 2.1% |
| 7/26/2024 | 3.0% | 4.6% | 8.0% |
| 4/26/2024 | 1.9% | 4.1% | 4.5% |
| 1/26/2024 | 2.0% | 6.0% | 6.1% |
| 10/27/2023 | -1.8% | 2.4% | 5.5% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 12 | 13 | 15 |
| # Negative | 11 | 10 | 8 |
| Median Positive | 1.9% | 3.1% | 4.3% |
| Median Negative | -1.9% | -2.1% | -3.6% |
| Max Positive | 6.2% | 9.8% | 11.7% |
| Max Negative | -5.2% | -6.3% | -7.3% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 9302025 | 10312025 | 10-Q 9/30/2025 |
| 6302025 | 8012025 | 10-Q 6/30/2025 |
| 3312025 | 4252025 | 10-Q 3/31/2025 |
| 12312024 | 2132025 | 10-K 12/31/2024 |
| 9302024 | 10252024 | 10-Q 9/30/2024 |
| 6302024 | 7262024 | 10-Q 6/30/2024 |
| 3312024 | 4262024 | 10-Q 3/31/2024 |
| 12312023 | 2152024 | 10-K 12/31/2023 |
| 9302023 | 10272023 | 10-Q 9/30/2023 |
| 6302023 | 7282023 | 10-Q 6/30/2023 |
| 3312023 | 4282023 | 10-Q 3/31/2023 |
| 12312022 | 2162023 | 10-K 12/31/2022 |
| 9302022 | 10282022 | 10-Q 9/30/2022 |
| 6302022 | 7292022 | 10-Q 6/30/2022 |
| 3312022 | 4292022 | 10-Q 3/31/2022 |
| 12312021 | 2172022 | 10-K 12/31/2021 |
Insider Activity
Expand for More| Owner | Title | Filing Date | Action | Price | Shares | TransactedValue | Value ofHeld Shares | Form | |
|---|---|---|---|---|---|---|---|---|---|
| 0 | Massey Sally | Chief Human Resources Officer | 11242025 | Sell | 80.89 | 1,237 | 100,061 | 1,112,318 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.